CELC
USDCelcuity Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$12.320
Máximo
$12.770
Mínimo
$12.320
Volumen
0.13M
Fundamentos de la Empresa
Capitalización de Mercado
476.0M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
0.23M
Bolsa
NCM
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
HC Wainwright & Co. Reiterates Buy on Celcuity, Maintains $27 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Celcuity with a Buy and maintains $27 price target.
Needham Reiterates Buy on Celcuity, Maintains $29 Price Target
Needham analyst Gil Blum reiterates Celcuity with a Buy and maintains $29 price target.
Celcuity Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update
The primary completion date of the PIK3CA wild-type cohort of the VIKTORIA-1 Phase 3 trial is expected in June 2025 and a topline data readout is anticipated in the third quarter of 2025 Enrollment is ongoing in the
Celcuity Inc. Schedules Release of First Quarter 2025 Financial Results and Webcast/Conference Call
MINNEAPOLIS, May 07, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its
Acciones Relacionadas
STRRP
Star Equity Holdings Inc. Series A Cumulative Perpetual Preferred Stock
PACS
PACS Group Inc.
PCQ
PIMCO California Municipal Income Fund
MBINO
Merchants Bancorp Depositary Shares Each Representing a 1/40th Interest in a Share of Series B Fixed-to-Floating Rate
FRT
Federal Realty Investment Trust
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.